We use cookies for a better user experience. Read our Privacy Policy
I Agree
Hematocrit Test Devices Market
Hematocrit Test Devices Market - Snapshot
Hematocrit test devices are type of in vitro diagnostic devices. These devices are computerized and specialized machines used for counting and characterizing white blood cells, platelets, and red blood cells. New generation hematocrit test devices are bench top and have micro sampling autoloaders with continuous loading capability. Additionally, these are equipped with barcode tracking technology. Moreover, point-of-care hematocrit test meter is a wireless instrument that operates on a single-use cartridge. Normal blood analyzers can complete blood count analysis with three-level WBC differentiation. The three major physical technologies used in blood analyzers are electrical impedance, flow cytometry, and fluorescent flow cytometry. The device has gained popularity, as it helps in effective evaluation of hematocrit value compared to manual method for evaluation of hematocrit parameter. Rise in blood-related diseases among the geriatric population is likely to drive the global hematocrit test devices market in the near future.
The global hematocrit test devices market is characterized by increase in incidence of chronic disease induced anemia across the world. The market is witnessing gradual rise in technological advancement supported by government funding and initiatives. The global hematocrit test devices market is projected to expand at steady pace from 2018 to 2026.
Increase in the geriatric population which is prone to blood borne diseases, large patient base in developing countries demanding proper treatment and diagnosis, and investments by public and private market players in R&D on hematocrit test devices for diagnostic testing of blood and treatment of hematology originated diseases drive the global hematocrit test devices market. However, lengthy regulatory approval procedure, significant investment required in innovation of diagnostic devices and solutions, and lack of awareness about importance of hematocrit tests in the diagnosis of diseases are likely to restrain the global market during the forecast period. Hematocrit test devices are gaining popularity among health care professionals, as these have proven to be effective in producing accurate complete blood count result which help health care professional in the treatment and diagnosis of blood borne diseases. Use of hematocrit test devices reduces the inaccurate evaluation of hematocrit value using manual calculation and are found to be more effective in complete blood count test than laboratory based manual procedures. Investment in innovation in hematocrit test meters or analyzers and partnerships for co-development and commercialization of hematocrit test devices are expected to fuel the growth of the global hematocrit test devices market in the near future.
In terms of product, the global hematocrit test devices market has been classified into blood analyzers, hematocrit test meters, and others. The others segment comprises consumables and accessories of hematocrit test devices. The blood analyzers segment includes hematology analyzers and blood gas systems. The blood analyzers segment is projected to dominate the market during the forecast period. Growth of the segment can be attributed to increase in usage of blood analyzers for various tests such as white blood cell count, reticulocytes analysis, and coagulation test complete blood count test, as these devices are easy to use, provide high level of precision and accuracy for red blood cell counting for evaluation of hematocrit parameters of individuals. Moreover, presence of key companies such as Sysmex Corporation and F. Hoffmann-La Roche Ltd. engaged in research & development and manufacture of innovative blood analyzers boosts the growth of the global market. Furthermore, initiatives taken by public and private organizations are aimed at installing new generation blood analyzers to provide better healthcare facilities and patient care. The relatively stable growth rate of the segment can be ascribed to high replacement rate and limited pipeline of blood analyzers. The hematocrit test meters segment is anticipated to expand at an above average growth rate during the forecast period despite the predominant use of blood analyzers in hematology testing. Preference for hematocrit test meters for hematocrit testing has increased among physicians and other end-users, as these are point-of-care devices and have the potential to provide decentralized patient care and hematocrit test at bedside and faster results than blood analyzers. Additionally, launch of products by Abbott, Nova Biomedical, and EKF Diagnostics are likely to drive the hematocrit test meters segment during the forecast period.
Based on end-user, the global hematocrit test devices market has been classified into hospitals & ambulatory surgical centers, clinics, diagnostic & pathology labs, and others. The hospitals and ambulatory surgical centers segment is expected to dominate the global hematocrit test devices market during the forecast period. In terms of region, the global hematocrit test devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global hematocrit test devices market in 2017. Europe was another major market for hematocrit test devices in 2017. Developed health care infrastructure and relatively high paying capacity of patients in North America and Europe compared to the developing countries provide assured business growth to new market entrants, which contributed to the high market share of these two regions. High growth rate of the diagnostic industry in India and China and investment made by global companies in China for establishment of sales subsidiaries for providing support and services to customers and to attract new potential customers are expected to propel the hematocrit test devices market in Asia Pacific.
Major players operating in the global hematocrit test devices market include Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers (Siemens AG), EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott Laboratories, HORIBA, Ltd., and Boule Diagnostics.
The global hematocrit test devices market has been segmented as follows:
|
by Product |
|
|
by End-user |
|
|
by Region |
|
Interested in this report?
Get a FREE sample now!
*Get Sample Report (PDF) sent to your email within minutes
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hematocrit Test Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Market Outlook
5.1.Prevalence of Anemia among pregnant women by key countries
5.2. Prevalence of Anemia by global and WHO region
5.3. Key Mergers & Acquisitions
5.4.Recent Product Launches and Approval
5.5.Comparative Analysis of Hematocrit Test Method
5.6.Epidemiological Overview of blood related Disease
6. Global Hematocrit Test Devices Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Blood Analyzers
6.3.2. Hematocrit Test Meters
6.3.3. Others
6.4. Market Attractiveness, by Product
7. Global Hematocrit Test Devices Market Analysis and Forecasts, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals & Ambulatory Surgical Centers
7.3.2. Clinics
7.3.3. Diagnostic & Pathology Labs
7.3.4. Others
7.4. Market Attractiveness, by End-user
8. Global Hematocrit Test Devices Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Hematocrit Test Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2016–2026
9.2.1. Blood Analyzers
9.2.2. Hematocrit Test Meters
9.2.3. Others
9.3. Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals & Ambulatory Surgical Centers
9.3.2. Clinics
9.3.3. Diagnostic & Pathology Labs
9.3.4. Others
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Hematocrit Test Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Blood Analyzers
10.2.2. Hematocrit Test Meters
10.2.3. Others
10.3. Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals & Ambulatory Surgical Centers
10.3.2. Clinics
10.3.3. Diagnostic & Pathology Labs
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Hematocrit Test Devices Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016–2026
11.2.1. Blood Analyzers
11.2.2. Hematocrit Test Meters
11.2.3. Others
11.3.Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals & Ambulatory Surgical Centers
11.3.2. Clinics
11.3.3. Diagnostic & Pathology Labs
11.3.4. Others
11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Hematocrit Test Devices Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016–2026
12.2.1. Blood Analyzers
12.2.2. Hematocrit Test Meters
12.2.3. Others
12.3.Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals & Ambulatory Surgical Centers
12.3.2. Clinics
12.3.3. Diagnostic & Pathology Labs
12.3.4. Others
12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Hematocrit Test Devices Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product, 2016–2026
13.2.1. Blood Analyzers
13.2.2. Hematocrit Test Meters
13.2.3. Others
13.3.Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals & Ambulatory Surgical Centers
13.3.2. Clinics
13.3.3. Diagnostic & Pathology Labs
13.3.4. Others
13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5.Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1.Market Player - Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis, by Company (2016)
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. NIHON KOHDEN CORPORATION
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Product Portfolio
14.4.1.3. SWOT Analysis
14.4.1.4. Strategic Overview
14.4.1.5. Financial Overview
14.4.2. F. Hoffmann-La Roche Ltd
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Product Portfolio
14.4.2.3. SWOT Analysis
14.4.2.4. Strategic Overview
14.4.2.5. Financial Overview
14.4.3. Danaher Corporation
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Product Portfolio
14.4.3.3. SWOT Analysis
14.4.3.4. Strategic Overview
14.4.3.5. Financial Overview
14.4.4. Siemens Healthineers (Siemens AG)
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Product Portfolio
14.4.4.3. SWOT Analysis
14.4.4.4. Strategic Overview
14.4.4.5. Financial Overview
14.4.5. EKF Diagnostics Holdings plc
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Product Portfolio
14.4.5.3. SWOT Analysis
14.4.5.4. Strategic Overview
14.4.5.5. Financial Overview
14.4.6. Sysmex Corporation
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Product Portfolio
14.4.6.3. SWOT Analysis
14.4.6.4. Strategic Overview
14.4.6.5. Financial Overview
14.4.7. Nova Biomedical
14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.7.2. Product Portfolio
14.4.7.3. SWOT Analysis
14.4.7.4. Strategic Overview
14.4.7.5. Financial Overview
14.4.8. Abbott Laboratories
14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.8.2. Product Portfolio
14.4.8.3. SWOT Analysis
14.4.8.4. Strategic Overview
14.4.8.5. Financial Overview
14.4.9. HORIBA, Ltd.
14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.9.2. Product Portfolio
14.4.9.3. SWOT Analysis
14.4.9.4. Strategic Overview
14.4.9.5. Financial Overview
14.4.10. Boule Diagnostics
14.4.6.10. Company Overview (HQ, Business Segments, Employee Strength)
14.4.10.2. Product Portfolio
14.4.10.3. SWOT Analysis
14.4.10.4. Strategic Overview
14.4.10.5. Financial Overview
15. Competition Landscape
List of Tables
Table 1: Prevalence of Anemia among Pregnant Women, by Key Countries
Table 2: Prevalence of anemia among children aged 6-59 months according to Global and WHO region
Table 3: Prevalence of Anemia among all women of reproductive age (15-49) years according to Global and WHO region
Table 4: Comparative Analysis of Hematocrit Test Methods
Table 5: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016-2026
Table 6: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 10: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 15: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 16: Asia Pacific Hematocrit Test Devices Market value (US$ Mn) Forecast, by End-user, 2016?2026
Table 17: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 18: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 19: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 20: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
Table 21: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Get a free copy if the report you purchased is updated within 90 days
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
